The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into country-level prepar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HEPATOLOGY 2023-09, Vol.78 (3), p.911-928
Hauptverfasser: Lazarus, Jeffrey V, Han, Hannah, Mark, Henry E, Alqahtani, Saleh A, Schattenberg, Jörn M, Soriano, Joan B, White, Trenton M, Zelber-Sagi, Shira, Dirac, M Ashworth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 928
container_issue 3
container_start_page 911
container_title HEPATOLOGY
container_volume 78
creator Lazarus, Jeffrey V
Han, Hannah
Mark, Henry E
Alqahtani, Saleh A
Schattenberg, Jörn M
Soriano, Joan B
White, Trenton M
Zelber-Sagi, Shira
Dirac, M Ashworth
description Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into country-level preparedness to address fatty liver disease through a whole-of-society lens. We developed 2 fatty liver disease-SDG score sets. The first included 6 indicators (child wasting, child overweight, noncommunicable disease mortality, a universal health coverage service coverage index, health worker density, and education attainment), covering 195 countries and territories between 1990 and 2017. The second included the aforementioned indicators plus an urban green space indicator, covering 60 countries and territories for which 2017 data were available. To develop the fatty liver disease-SDG score, indicators were categorized as "positive" or "negative" and scaled from 0 to 100. Higher scores indicate better preparedness levels. Fatty liver disease-SDG scores varied between countries and territories (n = 195), from 14.6 (95% uncertainty interval: 8.9 to 19.4) in Niger to 93.5 (91.6 to 95.3) in Japan; 18 countries and territories scored > 85. Regionally, the high-income super-region had the highest score at 88.8 (87.3 to 90.1) in 2017, whereas south Asia had the lowest score at 44.1 (42.4 to 45.8). Between 1990 and 2017, the fatty liver disease-SDG score increased in all super-regions, with the greatest increase in south Asia, but decreased in 8 countries and territories. The fatty liver disease-SDG score provides a strategic advocacy tool at the national and global levels for the liver health field and noncommunicable disease advocates, highlighting the multisectoral collaborations needed to address fatty liver disease, and noncommunicable diseases overall.
doi_str_mv 10.1097/HEP.0000000000000361
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_864062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2853944304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-1ee12c43d7cc878c0b48ec73176b2031415f8197cfb8642b3fe9cf355d0a9c2c3</originalsourceid><addsrcrecordid>eNpdkV1vFCEUhomxsdvqPzCGS2-m8rnAlTG1X0mTmlivCcOcabHssAKzZv99aXZtWrmBc87zvkBehD5SckKJUV8uz36ckJeLL-kbtKCSqY5zSd6iBWGKdIZyc4iOSvndGCOYfocOuZJGUqYX6OH2HvBdTL2LeHS1bnEMG8h4CAVcAfxzLtWFyfUR8HfYQEzrFUwVX6Qm8Gmeat7i4lMGPKaMqZH7boCC3TTgCjmHmp7q9-hgdLHAh_1-jH6dn92eXnbXNxdXp9-uOy-Eqh0FoMwLPijvtdKe9EKDV5yqZc8Ip4LKUVOj_NjrpWA9H8H4kUs5EGc88_wYdTvf8hfWc2_XOaxc3trkgt23HtoJbJOTJWv81x3fJisYfPtfdvGV7PVkCvf2Lm0sJUIwok1z-Lx3yOnPDKXaVSgeYnQTpLlYpiU3QnAiGip2qM-plAzj8z2U2KdgbQvW_h9sk316-cZn0b8k-SN7kKD3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2853944304</pqid></control><display><type>article</type><title>The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SWEPUB Freely available online</source><creator>Lazarus, Jeffrey V ; Han, Hannah ; Mark, Henry E ; Alqahtani, Saleh A ; Schattenberg, Jörn M ; Soriano, Joan B ; White, Trenton M ; Zelber-Sagi, Shira ; Dirac, M Ashworth</creator><creatorcontrib>Lazarus, Jeffrey V ; Han, Hannah ; Mark, Henry E ; Alqahtani, Saleh A ; Schattenberg, Jörn M ; Soriano, Joan B ; White, Trenton M ; Zelber-Sagi, Shira ; Dirac, M Ashworth ; GBD Fatty Liver Disease Sustainable Development Goal Collaborators ; on behalf of the GBD Fatty Liver Disease Sustainable Development Goal Collaborators</creatorcontrib><description>Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into country-level preparedness to address fatty liver disease through a whole-of-society lens. We developed 2 fatty liver disease-SDG score sets. The first included 6 indicators (child wasting, child overweight, noncommunicable disease mortality, a universal health coverage service coverage index, health worker density, and education attainment), covering 195 countries and territories between 1990 and 2017. The second included the aforementioned indicators plus an urban green space indicator, covering 60 countries and territories for which 2017 data were available. To develop the fatty liver disease-SDG score, indicators were categorized as "positive" or "negative" and scaled from 0 to 100. Higher scores indicate better preparedness levels. Fatty liver disease-SDG scores varied between countries and territories (n = 195), from 14.6 (95% uncertainty interval: 8.9 to 19.4) in Niger to 93.5 (91.6 to 95.3) in Japan; 18 countries and territories scored &gt; 85. Regionally, the high-income super-region had the highest score at 88.8 (87.3 to 90.1) in 2017, whereas south Asia had the lowest score at 44.1 (42.4 to 45.8). Between 1990 and 2017, the fatty liver disease-SDG score increased in all super-regions, with the greatest increase in south Asia, but decreased in 8 countries and territories. The fatty liver disease-SDG score provides a strategic advocacy tool at the national and global levels for the liver health field and noncommunicable disease advocates, highlighting the multisectoral collaborations needed to address fatty liver disease, and noncommunicable diseases overall.</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1097/HEP.0000000000000361</identifier><identifier>PMID: 37595128</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Asia, Southern ; Child ; Humans ; Non-alcoholic Fatty Liver Disease - epidemiology ; Noncommunicable Diseases ; Original : Steatohepatitis ; Sustainable Development</subject><ispartof>HEPATOLOGY, 2023-09, Vol.78 (3), p.911-928</ispartof><rights>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-1ee12c43d7cc878c0b48ec73176b2031415f8197cfb8642b3fe9cf355d0a9c2c3</citedby><cites>FETCH-LOGICAL-c447t-1ee12c43d7cc878c0b48ec73176b2031415f8197cfb8642b3fe9cf355d0a9c2c3</cites><orcidid>0000-0002-0633-4445 ; 0000-0001-9618-2299 ; 0000-0002-4224-4703 ; 0000-0002-1324-7497 ; 0000-0002-8022-4279</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,551,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37595128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:153478438$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Lazarus, Jeffrey V</creatorcontrib><creatorcontrib>Han, Hannah</creatorcontrib><creatorcontrib>Mark, Henry E</creatorcontrib><creatorcontrib>Alqahtani, Saleh A</creatorcontrib><creatorcontrib>Schattenberg, Jörn M</creatorcontrib><creatorcontrib>Soriano, Joan B</creatorcontrib><creatorcontrib>White, Trenton M</creatorcontrib><creatorcontrib>Zelber-Sagi, Shira</creatorcontrib><creatorcontrib>Dirac, M Ashworth</creatorcontrib><creatorcontrib>GBD Fatty Liver Disease Sustainable Development Goal Collaborators</creatorcontrib><creatorcontrib>on behalf of the GBD Fatty Liver Disease Sustainable Development Goal Collaborators</creatorcontrib><title>The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories</title><title>HEPATOLOGY</title><addtitle>Hepatology</addtitle><description>Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into country-level preparedness to address fatty liver disease through a whole-of-society lens. We developed 2 fatty liver disease-SDG score sets. The first included 6 indicators (child wasting, child overweight, noncommunicable disease mortality, a universal health coverage service coverage index, health worker density, and education attainment), covering 195 countries and territories between 1990 and 2017. The second included the aforementioned indicators plus an urban green space indicator, covering 60 countries and territories for which 2017 data were available. To develop the fatty liver disease-SDG score, indicators were categorized as "positive" or "negative" and scaled from 0 to 100. Higher scores indicate better preparedness levels. Fatty liver disease-SDG scores varied between countries and territories (n = 195), from 14.6 (95% uncertainty interval: 8.9 to 19.4) in Niger to 93.5 (91.6 to 95.3) in Japan; 18 countries and territories scored &gt; 85. Regionally, the high-income super-region had the highest score at 88.8 (87.3 to 90.1) in 2017, whereas south Asia had the lowest score at 44.1 (42.4 to 45.8). Between 1990 and 2017, the fatty liver disease-SDG score increased in all super-regions, with the greatest increase in south Asia, but decreased in 8 countries and territories. The fatty liver disease-SDG score provides a strategic advocacy tool at the national and global levels for the liver health field and noncommunicable disease advocates, highlighting the multisectoral collaborations needed to address fatty liver disease, and noncommunicable diseases overall.</description><subject>Asia, Southern</subject><subject>Child</subject><subject>Humans</subject><subject>Non-alcoholic Fatty Liver Disease - epidemiology</subject><subject>Noncommunicable Diseases</subject><subject>Original : Steatohepatitis</subject><subject>Sustainable Development</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNpdkV1vFCEUhomxsdvqPzCGS2-m8rnAlTG1X0mTmlivCcOcabHssAKzZv99aXZtWrmBc87zvkBehD5SckKJUV8uz36ckJeLL-kbtKCSqY5zSd6iBWGKdIZyc4iOSvndGCOYfocOuZJGUqYX6OH2HvBdTL2LeHS1bnEMG8h4CAVcAfxzLtWFyfUR8HfYQEzrFUwVX6Qm8Gmeat7i4lMGPKaMqZH7boCC3TTgCjmHmp7q9-hgdLHAh_1-jH6dn92eXnbXNxdXp9-uOy-Eqh0FoMwLPijvtdKe9EKDV5yqZc8Ip4LKUVOj_NjrpWA9H8H4kUs5EGc88_wYdTvf8hfWc2_XOaxc3trkgt23HtoJbJOTJWv81x3fJisYfPtfdvGV7PVkCvf2Lm0sJUIwok1z-Lx3yOnPDKXaVSgeYnQTpLlYpiU3QnAiGip2qM-plAzj8z2U2KdgbQvW_h9sk316-cZn0b8k-SN7kKD3</recordid><startdate>20230901</startdate><enddate>20230901</enddate><creator>Lazarus, Jeffrey V</creator><creator>Han, Hannah</creator><creator>Mark, Henry E</creator><creator>Alqahtani, Saleh A</creator><creator>Schattenberg, Jörn M</creator><creator>Soriano, Joan B</creator><creator>White, Trenton M</creator><creator>Zelber-Sagi, Shira</creator><creator>Dirac, M Ashworth</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-0633-4445</orcidid><orcidid>https://orcid.org/0000-0001-9618-2299</orcidid><orcidid>https://orcid.org/0000-0002-4224-4703</orcidid><orcidid>https://orcid.org/0000-0002-1324-7497</orcidid><orcidid>https://orcid.org/0000-0002-8022-4279</orcidid></search><sort><creationdate>20230901</creationdate><title>The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories</title><author>Lazarus, Jeffrey V ; Han, Hannah ; Mark, Henry E ; Alqahtani, Saleh A ; Schattenberg, Jörn M ; Soriano, Joan B ; White, Trenton M ; Zelber-Sagi, Shira ; Dirac, M Ashworth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-1ee12c43d7cc878c0b48ec73176b2031415f8197cfb8642b3fe9cf355d0a9c2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Asia, Southern</topic><topic>Child</topic><topic>Humans</topic><topic>Non-alcoholic Fatty Liver Disease - epidemiology</topic><topic>Noncommunicable Diseases</topic><topic>Original : Steatohepatitis</topic><topic>Sustainable Development</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lazarus, Jeffrey V</creatorcontrib><creatorcontrib>Han, Hannah</creatorcontrib><creatorcontrib>Mark, Henry E</creatorcontrib><creatorcontrib>Alqahtani, Saleh A</creatorcontrib><creatorcontrib>Schattenberg, Jörn M</creatorcontrib><creatorcontrib>Soriano, Joan B</creatorcontrib><creatorcontrib>White, Trenton M</creatorcontrib><creatorcontrib>Zelber-Sagi, Shira</creatorcontrib><creatorcontrib>Dirac, M Ashworth</creatorcontrib><creatorcontrib>GBD Fatty Liver Disease Sustainable Development Goal Collaborators</creatorcontrib><creatorcontrib>on behalf of the GBD Fatty Liver Disease Sustainable Development Goal Collaborators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>HEPATOLOGY</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lazarus, Jeffrey V</au><au>Han, Hannah</au><au>Mark, Henry E</au><au>Alqahtani, Saleh A</au><au>Schattenberg, Jörn M</au><au>Soriano, Joan B</au><au>White, Trenton M</au><au>Zelber-Sagi, Shira</au><au>Dirac, M Ashworth</au><aucorp>GBD Fatty Liver Disease Sustainable Development Goal Collaborators</aucorp><aucorp>on behalf of the GBD Fatty Liver Disease Sustainable Development Goal Collaborators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories</atitle><jtitle>HEPATOLOGY</jtitle><addtitle>Hepatology</addtitle><date>2023-09-01</date><risdate>2023</risdate><volume>78</volume><issue>3</issue><spage>911</spage><epage>928</epage><pages>911-928</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><abstract>Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into country-level preparedness to address fatty liver disease through a whole-of-society lens. We developed 2 fatty liver disease-SDG score sets. The first included 6 indicators (child wasting, child overweight, noncommunicable disease mortality, a universal health coverage service coverage index, health worker density, and education attainment), covering 195 countries and territories between 1990 and 2017. The second included the aforementioned indicators plus an urban green space indicator, covering 60 countries and territories for which 2017 data were available. To develop the fatty liver disease-SDG score, indicators were categorized as "positive" or "negative" and scaled from 0 to 100. Higher scores indicate better preparedness levels. Fatty liver disease-SDG scores varied between countries and territories (n = 195), from 14.6 (95% uncertainty interval: 8.9 to 19.4) in Niger to 93.5 (91.6 to 95.3) in Japan; 18 countries and territories scored &gt; 85. Regionally, the high-income super-region had the highest score at 88.8 (87.3 to 90.1) in 2017, whereas south Asia had the lowest score at 44.1 (42.4 to 45.8). Between 1990 and 2017, the fatty liver disease-SDG score increased in all super-regions, with the greatest increase in south Asia, but decreased in 8 countries and territories. The fatty liver disease-SDG score provides a strategic advocacy tool at the national and global levels for the liver health field and noncommunicable disease advocates, highlighting the multisectoral collaborations needed to address fatty liver disease, and noncommunicable diseases overall.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>37595128</pmid><doi>10.1097/HEP.0000000000000361</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-0633-4445</orcidid><orcidid>https://orcid.org/0000-0001-9618-2299</orcidid><orcidid>https://orcid.org/0000-0002-4224-4703</orcidid><orcidid>https://orcid.org/0000-0002-1324-7497</orcidid><orcidid>https://orcid.org/0000-0002-8022-4279</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-9139
ispartof HEPATOLOGY, 2023-09, Vol.78 (3), p.911-928
issn 0270-9139
1527-3350
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_864062
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SWEPUB Freely available online
subjects Asia, Southern
Child
Humans
Non-alcoholic Fatty Liver Disease - epidemiology
Noncommunicable Diseases
Original : Steatohepatitis
Sustainable Development
title The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A55%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20global%20fatty%20liver%20disease%20Sustainable%20Development%20Goal%20country%20score%20for%20195%20countries%20and%20territories&rft.jtitle=HEPATOLOGY&rft.au=Lazarus,%20Jeffrey%20V&rft.aucorp=GBD%20Fatty%20Liver%20Disease%20Sustainable%20Development%20Goal%20Collaborators&rft.date=2023-09-01&rft.volume=78&rft.issue=3&rft.spage=911&rft.epage=928&rft.pages=911-928&rft.issn=0270-9139&rft.eissn=1527-3350&rft_id=info:doi/10.1097/HEP.0000000000000361&rft_dat=%3Cproquest_swepu%3E2853944304%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2853944304&rft_id=info:pmid/37595128&rfr_iscdi=true